Bravado Pharmaceuticals
Bravado Pharmaceuticals LLC is a Lutz, Florida-based, privately-held pharmaceutical company (1-10 employees) that develops novel dosage forms and provides B2B contract pharmaceutical services to healthcare providers and patients under Florida pharmacy license PH35805.
- Company typePrivate
- Founded2017
- HeadquartersLutz, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Bravado Pharmaceuticals does
Bravado Pharmaceuticals LLC is a privately-held, Florida-incorporated pharmaceutical company founded in 2017 and headquartered at 4212 Cypress Gulch Dr, Lutz, FL, operating under Florida pharmacy license PH35805. The company is structured as a small (1-10 employee) B2B pharmaceutical services entity, with its website surfacing a Client Login portal, Proposal Request form, and Order Forms infrastructure indicative of contract development and services work. Its stated mission is to develop pharmaceutical dosage forms derived from what it describes as "quantum, molecular, land, air, sea, and cosmic" sources, with the stated objective of improving medicinal efficacies for healthcare providers and patients.
The underlying technology premise is novel dosage form development using a proprietary framework of multi-source ingredients, though no specific named products, formulation patents, or technical documentation are publicly disclosed. The company maintains no mobile application, no API, and no SDK, and its technology footprint is limited to a corporate website, basic B2B intake forms, and organic social media accounts on Facebook, LinkedIn, and Instagram. No research publications, clinical trial registrations, or third-party validation of its dosage form claims are documented in the source data.
Bravado's revenue mechanics are not publicly disclosed; the company appears to operate on a quote-driven, B2B contract basis targeting a horizontal segment of healthcare providers and patients within Florida (its only documented operating geography). There are no named customers, no partnerships, no distribution agreements, no funding rounds, and no leadership disclosures in the source data. As a result, the commercial profile of the company is largely opaque to external observers.
Bravado Pharmaceuticals firmographics
Firmographics- Name
- Bravado Pharmaceuticals
- Legal name
- Bravado Pharmaceuticals LLC
- Website
- https://bravapharm.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Bravado Pharmaceuticals LLC is a Lutz, Florida-based, privately-held pharmaceutical company (1-10 employees) that develops novel dosage forms and provides B2B contract pharmaceutical services to healthcare providers and patients under Florida pharmacy license PH35805.
- Ownership category
- akta.pro rank
Bravado Pharmaceuticals industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
Keywords
Where Bravado Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Lutz
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bravado Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain
Distribution channels1 record
Marketing channels3 records
Bravado Pharmaceuticals product offering
Product offeringCore offering
Bravado Pharmaceuticals is a contract development and research services provider in pharmaceutical manufacturing, focused on creating novel pharmaceutical dosage forms derived from quantum, molecular, land, air, sea, and cosmic sources. The company operates a B2B model via Client Login and Proposal Request portals, serving healthcare providers and pharmaceutical partners from its Lutz, Florida facility.
Product overview
Bravado Pharmaceuticals is a pharmaceutical company based in Lutz, Florida. The company focuses on creating pharmaceutical dosage forms with a mission to improve medicinal efficacies for mankind. Based on the available source content, the company operates through Business Platforms and Services pages, though no specific named products are documented in the provided materials. The company holds Florida pharmacy license #PH35805 and is located at 4212 Cypress Gulch Dr, Lutz, FL 33559.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Dosage Form Development Services Contract development and research services focused on creating novel pharmaceutical dosage forms derived from quantum, molecular, land, air, sea, and cosmic sources, with the objective of better medicinal efficacies. Targeted at healthcare providers and pharmaceutical partners.
Companies that use Bravado Pharmaceuticals
Customer profileSegments1 record
Ideal customer profiles1 record
Bravado Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bravado Pharmaceuticals partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
Bravado Pharmaceuticals competitors and assessment
Company assessmentBroad incumbents
- Piramal Pharma Solutions: Piramal offers contract development and commercial manufacturing across oral solids, sterile, and APIs; represents a comparable CDMO service model, though at substantially larger scale.
- Aenova Group: Aenova is a European-headquartered CDMO with strong solid and semi-solid dosage form development capabilities; relevant comparable for any contract pharma development peer Bravado would benchmark.
- Cambrex Corporation: Cambrex provides contract development and manufacturing of small molecule APIs and finished dosage forms; represents a more established comparable in pharmaceutical contract development.
- Catalent: Catalent is a global, large-scale CDMO across softgel, oral, biologic, and sterile dosage forms; sets the benchmark for outsourced dosage form development that a smaller participant like Bravado would compete against for contract work.
- Thermo Fisher Scientific (Patheon): Patheon, within Thermo Fisher's pharma services, offers commercial-scale contract development and manufacturing of finished dosage forms globally; analogous incumbents in the CDMO space Bravado targets.
Direct peers
- Metrics Contract Services: Metrics Contract Services offers small-to-mid-scale contract pharmaceutical development and manufacturing of solid oral dosage forms; one of the closest scale-comparable peers to Bravado.
- Noven Pharmaceuticals: Noven specializes in transdermal and oral drug delivery development and manufacturing; relevant comparable for a small pharmaceutical developer focused on novel dosage form formats.
- Alcami Corporation: Alcami is a US-based CDMO offering contract development and manufacturing of oral solid dosage forms, sterile injectables, and analytical services; directly comparable to Bravado's stated contract development and research positioning.
- Mikart, Inc. Mikart is a small US CDMO focused on contract development and manufacturing of oral solid and liquid dosage forms; comparable in scale and service mix to Bravado's stated offering.
- Pillar5 Pharma Inc. Pillar5 is a small US CDMO providing contract manufacturing and development of oral solid dose drug products; closely comparable to Bravado in terms of size, geography (North America), and service mix.
Market position
Strengths3 records
Weaknesses5 records
Competitive moat1 record
Key risks7 records
Key highlights5 records
Customer concentration
Bravado Pharmaceuticals social profiles
Digital presenceBravado Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bravado Pharmaceuticals leadership team
Management profileNumber of profiles
Bravado Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bravado Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bravado Pharmaceuticals
What does Bravado Pharmaceuticals do?
Bravado Pharmaceuticals is a contract development and research services provider in pharmaceutical manufacturing, focused on creating novel pharmaceutical dosage forms derived from quantum, molecular, land, air, sea, and cosmic sources. The company operates a B2B model via Client Login and Proposal Request portals, serving healthcare providers and pharmaceutical partners from its Lutz, Florida facility.
Is Bravado Pharmaceuticals a public or private company?
Bravado Pharmaceuticals is a private company. It is classified as unknown and is currently operating.
When was Bravado Pharmaceuticals founded?
Bravado Pharmaceuticals was founded in 2017. It employs 1 to 10 people.
Where is Bravado Pharmaceuticals based?
Bravado Pharmaceuticals is headquartered in Lutz, United States, in the North America region.
Who are Bravado Pharmaceuticals's main competitors?
Broad incumbents on record are Piramal Pharma Solutions, Aenova Group, Cambrex Corporation, Catalent and Thermo Fisher Scientific (Patheon). Direct peers are Metrics Contract Services, Noven Pharmaceuticals, Alcami Corporation, Mikart, Inc. and Pillar5 Pharma Inc..
Does Bravado Pharmaceuticals have an API?
No public API is recorded for Bravado Pharmaceuticals.
What industry is Bravado Pharmaceuticals in?
Bravado Pharmaceuticals's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development). Its NAICS code is 325412 and its SIC code is 2834.